Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

1st Repro > Female Pharmacology > Flashcards

Female Pharmacology Flashcards

1
Q

converts the androgens (Testosterone, Androstenedione and Hydroxyandrostenedione) to the respective estrogens, Estradiol, Estrone and Estriol)

A

the aromatase enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the three natural estrogens and which is the most potent?

A

Estradiol>Estrone>Estriol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

67% of circulating estrogens are bound to:

Where is estrogen metabolized?

A

sex steriod binding globulin and albumin

in the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

There are two nuclear estrogen receptors: _______and_____.They are ligand-activated transcription factors that increase or decrease the transcription of target genes. They have different tissue distributions and transcriptional regulatory effects on a wide number of target genes

A

ER-alpha and ER-beta.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Both ERs exist as multiple mRNA isoforms due to differential promoter use and alternative splicing. This concept of _________in ER conformation is central to understanding the mechanism of action of estrogen agonists and antagonists.

There is evidence of a cell membrane receptor for estrogen that signals non-transcription estrogenic effects.

A

ligand- mediated changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

enhances skeletal maturation and epiphyseal growth plate closure to limit linear growth and a role in feedback regulation of gonadotropin release

A

Estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Estrogen has positive effects on bone mass mainly by decreasing the number and activity of

A

osteoclasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Estrogens alter a number of pathways affecting the clotting cascade. Estrogens slightly____ a number of coagulation factors II, VII, IX, X, and XII, and________ the anticoagulation factors protein C, protein S, and antithrombin III. Fibrinolytic pathways also are affected, with decreased levels of plasminogen-activator inhibitor 1 (PAI-1) protein with a concomitant increase in fibrinolysis. Thus, estrogens______ both coagulation and fibrinolytic pathways – an imbalance in these opposing activities could cause adverse effects.

A

increase

decrease

increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Estrogens role in cervical mucus and endometrium

A

increases amount of cervical mucus and its water content to facilitate sperm penetration as well as promoting endometrial proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The naturally occurring hormone,______ is secreted by the ovary, mainly from the corpus luteum during the second half of the menstrual cycle. It’s synthesis is a component of corticosteroid biosynthesis cascade.

A

progesterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Progesterone acts on the progesterone receptor (a steroid receptor). It is a single gene that encodes two isoforms, PR-A and PR-B. How are they distributed?

A

ratios of each depend on tissue type and actvity depends on target tissue. MOstly results in stimulatory effect but sometimes inhibitory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In plasma progesterone binds to _______ and ______ while some progestins bind to SHBG

Progesterone has a RAPID first pass effect

A

corticosteroid binding globulin and albumin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Effect progesterone on GnRH pulses

A

Decreases frequency of GnRH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Effect of progesterone on estrogen driven endometrial proliferation

A

decreases estrogen-driven endometrial proliferation and leads to development of a secreatory endometrium.

*abrupt decline in progesterone at end of cycle is main determinant of the onset of menstration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AFfect of progesterone on cervical mucous and pregnancy

A

makes mucous viscid and maintains pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Effect of estrogen and progestin on endometrium

A

estrogen: proliferation

Progestin: secreatory to limit proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Affect of estorgen and progestin on cervical mucous

A

Estrogen decreases viscosity and increases amount of cervical mucous

Progestin **increases **and decreases amount

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Effect of estrogen and progestin on uterine contractions

A

Estrogen will favor rhythmic contractions and the progestin will decrease contractions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

collected from mare’s urine and contains sulfate esters of estrone, equilin, and other naturally occuring compounds

A

Conjugated equine estrogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

is the most potent of the natural estrogens in humans.
Preparations: Oral (micronized prep, because of first pass effect) patches, creams. The transdermal route minimizes hepatic effects of estrogens.

A

17B-estradiol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

(PREMARIN) contain sulfate esters of estrone, equilin and other equine compounds - **oral, esters are cleaved in the body. **

A

Conjugated equine estrogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

(estradiol valerate or estradiol cypionate) are available and are dissolved in oil and injected I.M. resulting in slow release.

A

Estrogen esters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

(a semisynthetic steroid) is the most potent estrogen available. (Oral) – C17

ethinyl inhibits first pass metabolism (t 1⁄2 = 13 to 27 hours).

A

Ethinyl estradiol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Therapeutic uses of estrogens

A

* Combination oral contraceptives

* Postmenopausal hormone replacement therapy

Failure of pituitary function/ovarian development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Toxic side effects of estrogen therapy

A

Gall Bladder disease (2-3 fold increase)

Oral estrogen increases risk of thromboembolic disease

nausea and vomiting

breast swelling

migraine headaches

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

When is estrogen therapy contraindicated?

A

pregnancy, estrogen-dependent cancers, undiagnosed uterine bleeding, thromboembolic disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

orally active with two isomers: a weak estrogen agonist and a potent estrogen antagonist

***works as a partial agonist at estrogen receptors.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

induces ovulation by inhibiting the action of stronger estrogens thus inhibiting feedback and increasing pulsatile gonadotropin release

A

Clomiphene

29
Q

MOA of Clomiphene

A

Clomiphene increases gonadotropin secretion and stimulates ovulation. It increases the amplitude of LH and FSH pulses without changing pulse frequency.

30
Q

Side effects of Clomiphene

A

ovarian hyperstimulaiton, multiple births, hot flashes

31
Q

Mixed estrognic and anti-estrogenic effects which are tissue specific (more anti-estrogenic in breast)

Used to treat and prevent breast cancer

A

Tamoxifen

32
Q

Estrogenic properties of SERMS such as Tamoxifen

A

hot flashes, sitms endometrial proliferation (more risk of endometrial cancer), increase TE events and is antiresorptive on bone

33
Q

By altering the conformation of the different ERs and changing interactions with co-activators and co-repressors in a cell-specific and promoter-specific contexts, ER ligands may have a broad spectrum of activities from purely anti-estrogenic in all tissues, to partially estrogenic in some tissues with anti-estrogenic or no activities in others, to purely estrogenic activities in all tissues.

A

SERMS – Selective Estrogen Receptor Modulators

34
Q

Treatment of breast cancer in women with ER-positive tumors, and it is now indicated as the hormonal treatment of choice for both early and advanced breast cancer in women of all ages. reduces the risk of developing contralateral breast cancer and is approved for primary prevention of breast cancer in women at high risk.

A

Tamoxifen

35
Q

MOA of Tamoxifen

A

exhibits anti-estrogenic, estrogenic, or mixed activity depending on the tissue. Competitive ER antagonist in breast tissue

36
Q

Treatment and prophylaxis of osteoporosis in postmenopausal women and breast cancer.

Reduces rate of bone loss and reduces risk for invasive breast cancer

A

Raloxifene

37
Q

MOA of Raloxifene

A

SERM that is an estrogen agonist in bone

38
Q

Estrogen properties of Raloxifene

A

reduction of cholesterol

hot flashes, increased thrombosis, leg cramps

no endometrial thickening

39
Q

Letrozole, Anastrozole, and Exemestane are all examples of:

A

Aromatase inhibitors

40
Q

Which aromatase inhibitors are steroidal?

non steroidal?

A

Exemestane

non: Letrozole and Anastrozole

41
Q

type I agents that are substrate analogs that act as suicide inhibitors to irreversibly inactivate aromatase.

A

Exemestane

42
Q

reversible inhibitors of aromatase

A

Nonsteroidal: Letrozole and Anastrozole

43
Q

Use of aromatase inhibitors

A

tx of breast cancer by reducing local and circulating estrogen levels

44
Q

major side effect of aromatase inhibitors

A

Hot flashes

45
Q

Three progesterone preperations

  1. low oral bioavailability
  2. progesterone analog
  3. ethinyl substituet at C17 to slow hepatic metabolism
A

Progesterone = low bioavailability

Medroxyprogesterone = progesteorne analogue that mostly progestational

Morethindrone = ethinyl substitute at C17

46
Q

racemic mixture of an inactive isomer and active isomer. Substituent results in a more potent progestin with less androgenic activity

A

Norgestrel

47
Q

testosterone derivatives, have primarily progestational rather than androgenic activity. Some synthetic progestins (especially the 19-nor compounds) have limited binding to glucocorticoid, androgen, and mineralocorticoid receptors, a property that accounts for some nonprogestational activities.

A

Progesterone

Methydorxyprogesterone

48
Q

spironolactone analogue with anti-mineralocorticoid and progestin activity.

A

Drospirenone

49
Q

What do we need to monitor when we give women Drospirenone?

A

Because it antagonizes the mineralocorticoid receptor, serum K+ should be monitored in **women at risk for hyperkalemia. **

50
Q

Key uses of progestins

A

Pregnancy prevention, emtional/physical symptoms of prementral dysphoric disorder, moderat acen vulgaris, hormonal contraceptives, post menopausal hormone replacement

51
Q

progestin is used to diagnose which diseases?

A

secondary amenorrhea and endometrial hyperplasia

52
Q

What are the three negative effects of progesterones?

A

Headaches, breakthrough bleeding, Adnrogenic actiosn like acne and hirsutism

53
Q

MOA of Mifepristone

A

competitive receptor antagonist for both progesterone receptors, although it may have some agonist activity.

54
Q

in combination with misoprostol or other prostaglandins, it is used for the termination of early pregnancy.

A

Mifepristone

55
Q

Mifepristone competitively blocks the _____receptor causing _____ breakdown and placental detachment and exuplsion of embryonic pregnancy. also sensitizes _____ to contractile actions of proglandins.

A

Progesterone

decidual

myometrium

56
Q

What do you need to take along with mifepristone?

A

misoprostal to cause contractiosn to rid of blastocyst

57
Q

selective progesterone receptor modulator that acts as partial agonist at progesterone receptors

A

Ulipristal

58
Q

MOA of Ulipristal

A

inhibits ovulation: inhibits LH release thus blocks LH induced follicular rupture in ovary. Should be taken up to five days after intercourse

59
Q

It inhibits LH release through interaction
with the hypothalamus and pituitary, and inhibition of LH-induced
follicular rupture in the ovary.

A

Ulipristal

60
Q

Side effects of Ulipristal

A

headache and abdominal pain

61
Q

Mainstay for hormonal contraception

A

Estrogen and progesterone and progesterone only

62
Q

Options for post-coital contraception

A

Combined levonorgesterel and ethinyl estradiol– 2 doses

Levonorgestreal alone (2 doses)

Ulipristal

63
Q

pill or high-dose estrogen-progestin combination pill is used for postcoital emergency contraception.

A

levonorgestrel

64
Q

(non-steroidal SERM) acts as an estrogen agonist in bone. It is used for the treatment and prevention of postmenopausal osteoporosis.

A

Raloxifene

65
Q

Therapeutic approach to postmenopausal hormone replacement therapy

A

need to to risk vs benefit analysis

a. estrogen/progestin combo therapy for INTACT uterus
b. Estrogen only (post hysterectomy)

66
Q

Mestranol is converted by the body to

A

ethinyl estradiol.

67
Q

(termed an antiestrogen) is a weak agonist of estrogen receptors in some tissues. It is used to treat infertility. It enhances gonadotropin secretion by antagonizing feedback suppression of GnRH. Can cause ovarian hyperstimulation.

A

Clomiphene

68
Q

is the most potent natural estrogen. It is in equilibrium with estrone

A

17B estradiol

1st Repro (16 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions